×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Maps
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
When will patients see personalized cancer vaccines? — Harvard Gazette
Harvard Gazette
Sooner than you may think, says researcher who recently won Sjöberg Prize for pioneering work in field.
1 month ago
After IPO, BioNTech nabs cell therapy startup Neon Therapeutics
Fierce Biotech
The acquirer is Germany's BioNTech, which has gotten off some monster raises and a middling $150 million IPO late last year and is paying just...
52 months ago
BioNTech Acquires Neon Therapeutics to Bolster Immuno-Oncology Pipeline
BioSpace
BioNTech Acquires Neon Therapeutics to Bolster Immuno-Oncology Pipeline ... Mainz, Germany-based BioNTech announced it was acquiring Cambridge,...
52 months ago
BioNTech acquires Neon at cheapest for $67m
European Biotechnology
mRNA cancer neoantigen specialist BioNTech AG is set to buy all shares of Neon Therapeutics, Inc. expanding its pipeline of...
52 months ago
Alterome Therapeutics Welcomes Andrew S. Chi, M.D., Ph.D., as Chief Medical Officer
Business Wire
Alterome Therapeutics, Inc., a next-generation precision oncology company pioneering the development of alteration-specific targeted...
9 months ago
BioNTech acquires T cell therapy-focused Neon for $67m
Pharmaceutical Technology
BioNTech has acquired Neon Therapeutics in an all stock transaction valued at $2.18 per share or approximately $67m.
52 months ago
Neon's vaccine improves survival rates in three cancer types
Clinical Trials Arena
Neon Therapeutics has reported that the combination of NEO-PV-01 with Opdivo led to improved progression-free survival in three cancer...
58 months ago
Newly-listed BioNTech buys Neon to boost cell therapy assets
PMLiVE
Just weeks after its $150m initial public offering, German biotech BioNTech has acquired troubled US counterpart Neon Therapeutics,...
52 months ago
People
Nature
Kathie M. Bishop (photo) has been appointed CSO at RNA-targeting gene therapy company Locana. A neuroscientist with 20 years of pharma...
56 months ago
Neon Therapeutics Named a Top Place to Work in Massachusetts by The Boston Globe
GlobeNewswire
CAMBRIDGE, Mass., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Neon Therapeutics (Nasdaq: NTGN) has been named one of the top places to work in...
66 months ago